NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 1.85% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 1.42% |
| SANA | Sana Biotechnology Inc | Healthcare | Biotechnology | 1.33% |
| KROS | Keros Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 1.26% |
| IGMS | IGM Biosciences Inc | Healthcare | Biotechnology | 1.22% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.21% |
| DYN | Dyne Therapeutics Inc | Healthcare | Biotechnology | 1.18% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 1.13% |
| MRUS | Merus BV | Healthcare | Biotechnology | 1.11% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.09% |
| INBX | Inhibrx Inc | Healthcare | Biotechnology | 1.06% |
| KURA | Kura Oncology Inc | Healthcare | Biotechnology | 1.06% |
| RAPT | RAPT Therapeutics Inc | Healthcare | Biotechnology | 1.04% |
| IMTX | Immatics NV | Healthcare | Biotechnology | 1.03% |
| CGEM | Cullinan Oncology LLC | Healthcare | Biotechnology | 1.03% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 1.03% |
| BCYC | Bicycle Therapeutics Ltd | Healthcare | Biotechnology | 1.01% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 1.01% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 0.99% |